Panel discussion on mantle cell lymphoma
Constantine Tam et al.
Preliminary results of the AIM trial of ibrutinib and venetoclax in mantle cell lymphoma
Mechanism of action of venetoclax (ABT-199) and its side effects
12th International Workshop on Non-Hodgkin Lymphoma (iwNHL) 2014: Day 2 meeting highlights
Anton Hagenbeek et al.
Developments in therapies for AML - chemotherapy, targeted therapy and immunotherapy
Hagop M. Kantarjian